ESMO24 . ZElLGENPHARMA Announces Promising Results For ZG006 in Treating Late-Stage SMALL CELL LUNG CANCER , Showing an ORR Of 66.7% And DCR Of 88.9% . More Details To Be Revealed At ESMO2024 .